Japan Infection Control Market Size, Share, By Type (Equipment Disinfectors, Sterilisation Equipment, Services and Consumables), By End Use (Hospitals, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, and Others), Japan Infection Control Market Size Industry Trend, Forecasts to 2035

Japan Infection Control Market Size Insights Forecasts to 2035

• Japan Infection Control Market Size 2024: USD 765.18 Million
• Japan Infection Control Market Size 2035:  USD 2027.1 Million
• Japan Infection Control Market Size CAGR 2024: 9.26%
• Japan Infection Control Market Size Segments: Type and End Use. 

The Japan Infection Control Market Size consists of a range of products & services that prevent or contain infections. Products include: sterilisation devices, disinfectants, Personal Protective Equipment (PPE), consumables and many support services. The objective of these products and services is to reduce the spread of infectious diseases, reduce HAIs, increase the safety of patients and employees, increase hygiene in facilities and provide better patient care. Furthermore, the Japan Infection Control Market Size is growing due to the growing incidence of HAIs and the older population, who are more vulnerable to infection. Moreover, with increased technological developments in sterilisation and diagnostic equipment, heightened public consciousness concerning hygiene due to the global pandemic, increasing private and public investment in infection control infrastructure, continued growth of new healthcare infrastructure, as well as increased regulation surrounding infection control, there is an increased need for infection control products & services within all healthcare and associated industries 

The Japan government, through the introduction of national public health policy frameworks, and financial incentives to facilities that comply with infection control standards. These policies include surveillance of multi-drug resistant organisms (MDROs), encouraging Infection Prevention and Control programs (IPC) within healthcare facilities, and preparation for crises by the MHLW. Incentives are used to improve prevention, surveillance, and reporting processes across the country.

The Japan Infection Control Market Size trends include new technology such as innovative sterilisation & disinfection systems, rapid point of care testing, greater use of digital tracking/monitoring systems to prevent HAI, expansion of multi-disciplinary IPC teams and new types of antimicrobial coatings. Increased awareness of infections drives the use of preventative infection control measures in all healthcare environments

Market Dynamics of the Japan Infection Control Market Size:

The Japan Infection Control Market Size is driving the Infection Control Market Size in Japan: increasing rates of infection in healthcare facilities, an aging population with higher rates of surgery, a general awareness of hygiene that has persisted post-pandemic and technological advances in disinfection and sterilisation procedures; strict Government regulations regarding infection control, rising levels of health care spending, expansion of hospitals and long-term care facilities, and the focus on patient safety from governmental agencies.

The Japan Infection Control Market Size faces restraints costs of technological and advanced infection prevention and control equipment, which limit the ability of smaller hospitals and clinics to invest in this type of equipment. Capital constraints limit their ability to invest in high-end technology. In addition, there are obstacles such as regulatory approvals, data privacy issues and a shortage of trained professionals to implement sophisticated infection management systems.

The Japan Infection Control Market Size will see opportunities for market growth due to increased demand for advanced technologies such as ultraviolet (UV) disinfection, automated sterilisation and artificial intelligence (AI)-based monitoring systems. Additionally, the expansion of infection control solutions into home healthcare, long-term care facilities and outpatient clinics presents new opportunities to meet future demand. Increased government funding, increased private investing, and innovation in green disinfectants will also fuel growth in the Japan Infection Control Market Size for many years to come.

Market Segmentation

The Japan Infection Control Market Size share is classified into type and end use.

By Type:

The Japan Infection Control Market Size is divided by type into equipment disinfectors, sterilisation equipment, services, and consumables. Among these, the consumables segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The consumables segment dominates because these products are used daily and require frequent replacement. High usage of disinfectants, gloves, masks, gowns, and sterilisation supplies across hospitals, clinics, and long-term care facilities drives continuous demand. Post-pandemic hygiene awareness, infection prevention protocols, and rising patient volumes further strengthen consumables’ market leadership.

By End Use:

The Japan Infection Control Market is segmented by end use into hospitals, medical device companies, clinical laboratories, pharmaceutical companies, and others. Among these, the hospitals segment dominated the market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

The dominance of the hospital segment is attributed to high patient volumes and increased susceptibility to healthcare-associated infections (HAIs). Strict regulatory standards mandate comprehensive infection prevention measures, including sterilization equipment, disinfectants, personal protective equipment (PPE), and monitoring systems. Continuous emphasis on patient and staff safety, reinforced post-pandemic hygiene protocols, and the frequent use of infection control consumables further position hospitals as the largest end-use segment in Japan’s infection control market.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Japan Infection Control Market Size, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Key Companies in Japan Infection Control Market Size:

• 3M Company
• Belimed AG.
• Ecolab Inc.
• Getinge AB
• Advanced Sterilisation Products (Fortive).
• Cantel Medical Corp.
• STERIS PLC
• MMM Group.
• Matachana Group.
• ASP Japan LLC (Advanced Sterilisation Products).
• Getinge Group Japan Co., Ltd.
• Taiko Pharmaceutical Co., Ltd
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan Infection Control Market Size based on the below-mentioned segments

Japan Infection Control Market Size, By Type

• Equipment Disinfectors
• Sterilisation Equipment
• Services
• Consumables

Japan Infection Control Market Size, by End Use.

• Hospitals
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Companies
• Others